Tokyo Tape
Sign in
← Takeda Pharmaceutical

Annual report

4502.TEDINET S100YB5L
Period2025-04-01 → 2026-03-31
Filed2026-06-17
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥4.51T2025-04-01 → 2026-03-31Cons.Revenue IFRS
Revenue¥4.58T2024-04-01 → 2025-03-31Cons.Revenue IFRS
Revenue¥4.26T2023-04-01 → 2024-03-31vCons.Revenue IFRS (5-year summary)
Revenue¥4.03T2022-04-01 → 2023-03-31vCons.Revenue IFRS (5-year summary)
Revenue¥3.57T2021-04-01 → 2022-03-31vCons.Revenue IFRS (5-year summary)
Operating income¥6.2bn2025-04-01 → 2026-03-31Cons.Operating profit loss IFRS
Operating income¥342.6bn2024-04-01 → 2025-03-31Cons.Operating profit loss IFRS
Profit before tax−¥142.4bn2025-04-01 → 2026-03-31Cons.Profit loss before tax IFRS
Profit before tax¥175.1bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS
Profit before tax¥52.8bn2023-04-01 → 2024-03-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥375.1bn2022-04-01 → 2023-03-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥302.6bn2021-04-01 → 2022-03-31vCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)−¥152.4bn2025-04-01 → 2026-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥107.9bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥144.1bn2023-04-01 → 2024-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥317.0bn2022-04-01 → 2023-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥230.1bn2021-04-01 → 2022-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income−¥152.1bn2025-04-01 → 2026-03-31Cons.Profit loss IFRS
Net income¥108.1bn2024-04-01 → 2025-03-31Cons.Profit loss IFRS
Net income¥144.2bn2023-04-01 → 2024-03-31vCons.Profit loss IFRS (5-year summary)
Net income¥317.0bn2022-04-01 → 2023-03-31vCons.Profit loss IFRS (5-year summary)
Net income¥230.2bn2021-04-01 → 2022-03-31vCons.Profit loss IFRS (5-year summary)
Total assets¥15.51Tat 2026-03-31Cons.Assets IFRS
Total assets¥14.25Tat 2025-03-31Cons.Assets IFRS
Total assets¥15.11Tat 2024-03-31vCons.Total assets IFRS (5-year summary)
Total assets¥13.96Tat 2023-03-31vCons.Total assets IFRS (5-year summary)
Total assets¥13.18Tat 2022-03-31vCons.Total assets IFRS (5-year summary)
Total liabilities¥8.08Tat 2026-03-31Cons.Liabilities IFRS
Total liabilities¥7.31Tat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥7.43Tat 2026-03-31Cons.Equity IFRS
Net assets / equity¥6.94Tat 2025-03-31Cons.Equity IFRS
Net assets / equity¥7.27Tat 2024-03-31vCons.Equity IFRS
Equity (owners)¥7.43Tat 2026-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥6.94Tat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥595.1bnat 2026-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥385.1bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥457.8bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Cash & equivalents¥533.5bnat 2023-03-31vCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥849.7bnat 2022-03-31vCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥1.04T2025-04-01 → 2026-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.06T2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥716.3bn2023-04-01 → 2024-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥977.2bn2022-04-01 → 2023-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.12T2021-04-01 → 2022-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥369.1bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥367.1bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥463.9bn2023-04-01 → 2024-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥607.1bn2022-04-01 → 2023-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥198.1bn2021-04-01 → 2022-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥496.8bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥751.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥354.4bn2023-04-01 → 2024-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥709.1bn2022-04-01 → 2023-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.07T2021-04-01 → 2022-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥-96.752025-04-01 → 2026-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥68.362024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥92.092023-04-01 → 2024-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥204.292022-04-01 → 2023-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥147.142021-04-01 → 2022-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-96.752025-04-01 → 2026-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.232024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥91.162023-04-01 → 2024-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥201.942022-04-01 → 2023-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥145.872021-04-01 → 2022-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥4,702.66at 2026-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,407.01at 2025-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,635.56at 2024-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,087.49at 2023-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,665.61at 2022-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio47.9%at 2026-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.7%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.1%at 2024-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.5%at 2023-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.1%at 2022-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE-2.1%2025-04-01 → 2026-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE1.5%2024-04-01 → 2025-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE2.1%2023-04-01 → 2024-03-31vCons.Rate of return on equity IFRS (5-year summary)
ROE5.3%2022-04-01 → 2023-03-31vCons.Rate of return on equity IFRS (5-year summary)
ROE4.2%2021-04-01 → 2022-03-31vCons.Rate of return on equity IFRS (5-year summary)
Employees47,029at 2026-03-31Cons.Number of employees
Employees47,455at 2025-03-31Cons.Number of employees
Employees49,281at 2024-03-31vCons.Number of employees
Employees49,095at 2023-03-31vCons.Number of employees
Employees47,347at 2022-03-31vCons.Number of employees
Revenue¥591.6bn2025-04-01 → 2026-03-31StandaloneNet sales
Revenue¥580.4bn2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥595.6bn2023-04-01 → 2024-03-31vStandaloneNet sales (5-year summary)
Revenue¥632.1bn2022-04-01 → 2023-03-31vStandaloneNet sales (5-year summary)
Revenue¥764.3bn2021-04-01 → 2022-03-31vStandaloneNet sales (5-year summary)
Operating income¥21.1bn2025-04-01 → 2026-03-31StandaloneOperating income
Operating income¥36.9bn2024-04-01 → 2025-03-31StandaloneOperating income
Ordinary income¥205.5bn2025-04-01 → 2026-03-31StandaloneOrdinary income
Ordinary income¥86.6bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income¥286.4bn2023-04-01 → 2024-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥340.1bn2022-04-01 → 2023-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥550.9bn2021-04-01 → 2022-03-31vStandaloneOrdinary income loss (5-year summary)
Profit before tax¥187.0bn2025-04-01 → 2026-03-31StandaloneIncome before income taxes
Profit before tax¥199.3bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Net income¥197.3bn2025-04-01 → 2026-03-31StandaloneProfit loss
Net income¥152.8bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income¥338.9bn2023-04-01 → 2024-03-31vStandaloneNet income loss (5-year summary)
Net income¥330.6bn2022-04-01 → 2023-03-31vStandaloneNet income loss (5-year summary)
Net income¥324.4bn2021-04-01 → 2022-03-31vStandaloneNet income loss (5-year summary)
Total assets¥9.64Tat 2026-03-31StandaloneAssets
Total assets¥9.49Tat 2025-03-31StandaloneAssets
Total assets¥9.76Tat 2024-03-31vStandaloneTotal assets (5-year summary)
Total assets¥9.41Tat 2023-03-31vStandaloneTotal assets (5-year summary)
Total assets¥9.64Tat 2022-03-31vStandaloneTotal assets (5-year summary)
Total liabilities¥5.88Tat 2026-03-31StandaloneLiabilities
Total liabilities¥5.50Tat 2025-03-31StandaloneLiabilities
Net assets / equity¥3.76Tat 2026-03-31StandaloneNet assets
Net assets / equity¥3.99Tat 2025-03-31StandaloneNet assets
Net assets / equity¥4.09Tat 2024-03-31vStandaloneNet assets
Net assets / equity¥4.21Tat 2023-03-31vStandaloneNet assets (5-year summary)
Net assets / equity¥4.29Tat 2022-03-31vStandaloneNet assets (5-year summary)
Cash and deposits¥73.9bnat 2026-03-31StandaloneCash and deposits
Cash and deposits¥169.6bnat 2025-03-31StandaloneCash and deposits
EPS (basic)¥125.292025-04-01 → 2026-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥96.792024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥216.62023-04-01 → 2024-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥213.062022-04-01 → 2023-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥207.52021-04-01 → 2022-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥125.262025-04-01 → 2026-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥96.782024-04-01 → 2025-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥216.562023-04-01 → 2024-03-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥213.052022-04-01 → 2023-03-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥207.52021-04-01 → 2022-03-31vStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥2002025-04-01 → 2026-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1962024-04-01 → 2025-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1882023-04-01 → 2024-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802022-04-01 → 2023-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802021-04-01 → 2022-03-31vStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,378.68at 2026-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,534.39at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,604.87at 2024-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥2,704.87at 2023-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥2,769.31at 2022-03-31vStandaloneNet assets per share (5-year summary)
Equity ratio39.0%at 2026-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.0%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio41.9%at 2024-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio44.7%at 2023-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio44.5%at 2022-03-31vStandaloneEquity to asset ratio (5-year summary)
ROE5.1%2025-04-01 → 2026-03-31StandaloneRate of return on equity (5-year summary)
ROE3.8%2024-04-01 → 2025-03-31StandaloneRate of return on equity (5-year summary)
ROE8.2%2023-04-01 → 2024-03-31vStandaloneRate of return on equity (5-year summary)
ROE7.8%2022-04-01 → 2023-03-31vStandaloneRate of return on equity (5-year summary)
ROE7.4%2021-04-01 → 2022-03-31vStandaloneRate of return on equity (5-year summary)
Shares issued1,591,229,000at 2026-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,590,950,000at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,582,419,000at 2024-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,582,296,000at 2023-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,582,253,000at 2022-03-31vStandaloneTotal number of issued shares (5-year summary)
Employees4,792at 2026-03-31StandaloneNumber of employees
Employees4,808at 2025-03-31StandaloneNumber of employees
Employees5,474at 2024-03-31vStandaloneNumber of employees
Employees5,486at 2023-03-31vStandaloneNumber of employees
Employees5,149at 2022-03-31vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2026-03-3147029 pure
Pharmaceutical Businessreportable segmentemployeesat 2026-03-314792 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,774
ItemContextValueUnit
Payout ratio (5-year summary)Prior2YearDuration_NonConsolidatedMember0.868
Payout ratio (5-year summary)Prior1YearDuration_NonConsolidatedMember2.025
Payout ratio (5-year summary)CurrentYearDuration_NonConsolidatedMember1.596
Number of employeesPrior4YearInstant_NonConsolidatedMember5149
Number of employeesPrior3YearInstant_NonConsolidatedMember5486
Number of employeesPrior2YearInstant_NonConsolidatedMember5474
Number of employeesPrior1YearInstant_NonConsolidatedMember4808
Number of employeesCurrentYearInstant_NonConsolidatedMember4792
Total shareholder returnPrior4YearInstant_NonConsolidatedMember0.923
Total shareholder returnPrior3YearInstant_NonConsolidatedMember1.182
Total shareholder returnPrior2YearInstant_NonConsolidatedMember1.187
Total shareholder returnPrior1YearInstant_NonConsolidatedMember1.294
Total shareholder returnCurrentYearInstant_NonConsolidatedMember1.658
Total return on share price indexPrior4YearInstant_NonConsolidatedMember1.020
Total return on share price indexPrior3YearInstant_NonConsolidatedMember1.079
Total return on share price indexPrior2YearInstant_NonConsolidatedMember1.525
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.502
Total return on share price indexCurrentYearInstant_NonConsolidatedMember2.022
Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metricsCurrentYearInstant_Row2Member79
Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metricsCurrentYearInstant_Row4Member70
Gross scope1 greenhouse gas emissions scope1 and2 greenhouse gas emissionsCurrentYearDuration_ConsolidatedAccountingGroupMember246000
Gross scope2 greenhouse gas emissions scope1 and2 greenhouse gas emissionsCurrentYearDuration_ConsolidatedAccountingGroupMember28000
Gross scope3 greenhouse gas emissionsCurrentYearDuration_ConsolidatedAccountingGroupMember2536000
Research and development expenses research and development activitiesCurrentYearDuration675900000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration2001000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1591229109
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1591266609
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1591229109
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1591266609
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember2
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember229
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember51
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember3296
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember1206
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember1360
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember617092
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember623236
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember13
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember4235278
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember1009453
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember473007
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember6672551
Number of shares held number of units foreign individual investorsCurrentYearInstant_OrdinaryShareMember6101
Number of shares held number of units individuals and othersCurrentYearInstant_OrdinaryShareMember3495303
Number of shares held number of units totalCurrentYearInstant_OrdinaryShareMember15891706
Number of shares held shares less than one unitCurrentYearInstant_OrdinaryShareMember2058509
Percentage of shareholdings national and local governmentsCurrentYearInstant_OrdinaryShareMember0.0000
Percentage of shareholdings financial institutionsCurrentYearInstant_OrdinaryShareMember0.2665
Percentage of shareholdings financial service providersCurrentYearInstant_OrdinaryShareMember0.0635

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2026-03-31pass rounding
balance sheet identitynon_consolidated 2025-03-31pass
balance sheet identitynon_consolidated 2026-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · net assetsnon_consolidated 2026-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2026-03-31pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenueconsolidated 2024-04-01/2025-03-31pass
statement vs summary · revenueconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2025-04-01/2026-03-31pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2026-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass
statement vs summary · total assetsnon_consolidated 2026-03-31pass